trial · primary record
QLS-111 Ophthalmic Solution (0.015%)
Non-proliferative Diabetic Retinopathy (NPDR)
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 9 |
| Primary completion | 2026-10-01 |
| Primary endpoint | Change from Baseline in blood flow to the posterior segment of the eye. |
| Registry ID | NCT07354477 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:12.148Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07354477
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.